These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23644738)

  • 21. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.
    Hermanson DL; Bendzick L; Pribyl L; McCullar V; Vogel RI; Miller JS; Geller MA; Kaufman DS
    Stem Cells; 2016 Jan; 34(1):93-101. PubMed ID: 26503833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluripotent stem cell-derived natural killer cells for cancer therapy.
    Knorr DA; Kaufman DS
    Transl Res; 2010 Sep; 156(3):147-54. PubMed ID: 20801411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors.
    Choi KD; Vodyanik MA; Slukvin II
    J Clin Invest; 2009 Sep; 119(9):2818-29. PubMed ID: 19726877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of clinically compliant human embryonic stem cells in an autologous feeder-free system.
    Fu X; Toh WS; Liu H; Lu K; Li M; Cao T
    Tissue Eng Part C Methods; 2011 Sep; 17(9):927-37. PubMed ID: 21561302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum-free and feeder-free culture expansion of human embryonic stem cells.
    Wagner KE; Vemuri MC
    Methods Mol Biol; 2010; 584():109-19. PubMed ID: 19907974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for expansion of undifferentiated human embryonic and pluripotent stem cells in suspension.
    Baharvand H; Larijani MR; Yousefi M
    Methods Mol Biol; 2012; 873():217-26. PubMed ID: 22528357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
    Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
    Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.
    Zeng J; Tang SY; Toh LL; Wang S
    Stem Cell Reports; 2017 Dec; 9(6):1796-1812. PubMed ID: 29173894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of human pluripotent stem cell-derived natural killer cells for immunotherapy under chemically defined conditions.
    Matsubara H; Niwa A; Nakahata T; Saito MK
    Biochem Biophys Res Commun; 2019 Jul; 515(1):1-8. PubMed ID: 30948156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.
    Woll PS; Grzywacz B; Tian X; Marcus RK; Knorr DA; Verneris MR; Kaufman DS
    Blood; 2009 Jun; 113(24):6094-101. PubMed ID: 19365083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivation and characterization of human embryonic stem cells on human amnion epithelial cells.
    Lai D; Wang Y; Sun J; Chen Y; Li T; Wu Y; Guo L; Wei C
    Sci Rep; 2015 May; 5():10014. PubMed ID: 25950719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. iPSC-Derived Natural Killer Cells for Cancer Immunotherapy.
    Karagiannis P; Kim SI
    Mol Cells; 2021 Aug; 44(8):541-548. PubMed ID: 34373366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro.
    Tang PM; Tang PC; Chung JY; Hung JSC; Wang QM; Lian GY; Sheng J; Huang XR; To KF; Lan HY
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.
    Rajala K; Lindroos B; Hussein SM; Lappalainen RS; Pekkanen-Mattila M; Inzunza J; Rozell B; Miettinen S; Narkilahti S; Kerkelä E; Aalto-Setälä K; Otonkoski T; Suuronen R; Hovatta O; Skottman H
    PLoS One; 2010 Apr; 5(4):e10246. PubMed ID: 20419109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity.
    Woll PS; Martin CH; Miller JS; Kaufman DS
    J Immunol; 2005 Oct; 175(8):5095-103. PubMed ID: 16210613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline supplementation allows for the culture of human ESCs/iPSCs with media changes at 3-day intervals.
    Chang MY; Oh B; Rhee YH; Lee SH
    Stem Cell Res; 2015 Nov; 15(3):608-613. PubMed ID: 26513556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures.
    King FW; Ritner C; Liszewski W; Kwan HC; Pedersen A; Leavitt AD; Bernstein HS
    Stem Cells Dev; 2009 Dec; 18(10):1441-50. PubMed ID: 19254177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected].
    Lu SJ; Kelley T; Feng Q; Chen A; Reuveny S; Lanza R; Oh SK
    Regen Med; 2013 Jul; 8(4):413-24. PubMed ID: 23826696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.